Rebecca McKee
Family · Bad Axe, MINPI 1881156594
Payments from drug & device makers
Across 94 payments — averaging $18.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$419
- Mylan Specialty L.p.$219
- Lilly USA, LLC$207
- GSK$166
- AbbVie$135
- Exact Sciences$83
- plus $469 from 12 others
What the payments were for
- Food & beverage$1,697100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 24 | $419 |
| Mylan Specialty L.p. | 11 | $219 |
| Lilly USA, LLC | 12 | $207 |
| GSK | 10 | $166 |
| AbbVie | 6 | $135 |
| Exact Sciences | 5 | $83 |
| Pfizer | 5 | $82 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $70 |
| Novartis | 4 | $62 |
| Amgen(2 entities) | 2 | $36 |
| Dexcom, Inc. | 2 | $34 |
| Baxter Healthcare | 1 | $27 |
| Boehringer Ingelheim | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Vertex | 1 | $17 |
| Merck | 1 | $12 |
How this compares
$1,697 in reported general payments places this provider in the 80th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 87 | $95,081 |
| JardianceEmpagliflozin | 67 | $58,706 |
| EliquisApixaban | 48 | $56,921 |
| TrulicityDulaglutide | 30 | $28,603 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $20,213 |
| FarxigaDapagliflozin Propanediol | 13 | $10,822 |
| Tresiba Flextouch U-200Insulin Degludec | 13 | $7,459 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 17 | $3,062 |
| Levemir FlexpenInsulin Detemir | 18 | $2,940 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $2,926 |
| Arnuity ElliptaFluticasone Furoate | 12 | $2,408 |
| Atorvastatin Calcium | 170 | $2,019 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 37 | $1,856 |
| Ventolin HfaAlbuterol Sulfate | 15 | $1,413 |
| Potassium Chloride | 64 | $1,169 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $419 | $95,08187 claims |
| Boehringer IngelheimJardiance | $20 | $58,70667 claims |
| PfizerEliquis | $82 | $56,92148 claims |
| Lilly USA, LLCTrulicity | $207 | $28,60330 claims |
| GSKTrelegy Ellipta, Arnuity Ellipta | $166 | $22,62135 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,657 family providers in Michigan.
Other family in Bad Axe
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.